TRANSCAN-3ERA-NET call 2022 on hard-to-treat cancers will be announced soon
The TRANSCAN-3 ERA-NET will shortly launch a new multinational call for proposals on "Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy". Proposals must be centred on one or more of the hard-to-treat-cancers (HTTC) subtypes characterized by very poor prognosis (5-year survival rate<25%) and for which survival has not improved significantly over the last decades, namely glioblastoma, oesophageal, pancreatic, gallbladder, liver, and lung/pleural cancers.
Publication date: 10 May 2022